$URGN 4/A SEC Filings

Filed On	Filing
12 Feb 2024	Form 4/A: Kim Dong, Chief Financial Officer Received 3,333 shares by exercise or conversion
12 Feb 2024	Form 4/A: Kim Dong, Chief Financial Officer Granted 20,000 Stock Option (right to buy)
05 Feb 2024	Form 4/A: Smith Jason Drew, General Counsel Sold 4,993 shares ($78.8K)
05 Feb 2024	Form 4/A: Schoenberg Mark, Chief Medical Officer Sold 3,789 shares ($59.8K)
28 Jul 2023	Form 4/A: Robinson James A. Jr., Director Granted 20,000 Stock Option (right to buy)
28 Feb 2023	Form 4/A: Nussbaum Ran, Director Received 1,030 shares by exercise or conversion ($5.15K)
28 Feb 2023	Form 4/A: Nussbaum Ran, Director Received 47,999 shares by exercise or conversion ($285K)
12 Jul 2021	Form 4/A: Barrett Elizabeth A., Chief Executive Officer Received 8,807 shares by exercise or conversion · Received 8,807 shares by exercise or conversion · Received 8,807 shares by exercise or conversion · 4 more
12 Jul 2021	Form 4/A: Barrett Elizabeth A., Chief Executive Officer Received 8,807 shares by exercise or conversion · Received 8,807 shares by exercise or conversion · Received 8,807 shares by exercise or conversion · 1 more
09 Jun 2021	Form 4/A: Belldegrun Arie, Director Received 3,241 shares by exercise or conversion ($16.2K)
09 Jun 2021	Form 4/A: Nussbaum Ran, Director Received 1,030 shares by exercise or conversion ($5.15K)
05 Oct 2020	Form 4/A: Smith Jason Drew, General Counsel Granted 60,000 Employee Stock Option (right to buy) · Granted 25,000 Restricted Stock Unit

Comments